Ost-müük Virios Therapeutics, Inc. - VIRI CFD
Lisa lemmikuks- Kokkuvõte
- Ajaloolised andmed
- Sündmused
- Tuluaruanne
- Bilanss
- Rahavood
- Omand
Hinnavahe | 0.05 | ||||||||
Pika positsiooni ööpäeva tasu
Long position overnight fee
Mine platvormile | -0.025457% | ||||||||
Lühikese positsiooni ööpäeva tasu
Short position overnight fee
Mine platvormile | 0.003235% | ||||||||
Ööpäeva tasu aeg | 21:00 (UTC) | ||||||||
Min kauplemise kogus | 1 | ||||||||
Valuuta | USD | ||||||||
Tagatis | 20% | ||||||||
Aktsiabörs | United States of America | ||||||||
Kauplemise vahendustasu | 0% |
*Information provided by Capital.com
Eelmine sulgemine* | 1.47 |
Avatud* | 1.51 |
Aastane muutus* | -64.8% |
Päeva ulatus* | 1.45 - 1.58 |
52 nädala ulatus | 0.22-9.11 |
Keskmine maht (10 päeva) | 1.13M |
Keskmine maht (3 kuud) | 62.58M |
Turukapitalisatsioon | 27.31M |
P/E suhtarv | -100.00K |
Ringluses olevad aktsiad | 18.33M |
Tulu | N/A |
EPS | -1.24 |
Dividendid (% kasumist) | N/A |
Beeta | -100.00K |
Järgmine tuluaruande kuupäev | N/A |
Kõigi andmete allikas on Refinitiv, välja arvatud tärniga märgitud, kus *-ga andmed on esitanud Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Sulgemishind | Change (%) | Avamishind | High | Low |
---|---|---|---|---|---|---|
Jun 2, 2023 | 1.47 | -0.13 | -8.13% | 1.60 | 1.61 | 1.38 |
Jun 1, 2023 | 1.61 | -0.12 | -6.94% | 1.73 | 1.73 | 1.51 |
May 31, 2023 | 1.69 | 0.11 | 6.96% | 1.58 | 1.77 | 1.58 |
May 30, 2023 | 1.62 | 0.15 | 10.20% | 1.47 | 1.76 | 1.42 |
May 26, 2023 | 1.42 | 0.23 | 19.33% | 1.19 | 1.45 | 1.19 |
May 25, 2023 | 1.19 | -0.13 | -9.85% | 1.32 | 1.40 | 1.18 |
May 24, 2023 | 1.32 | 0.04 | 3.13% | 1.28 | 1.41 | 1.27 |
May 23, 2023 | 1.21 | 0.13 | 12.04% | 1.08 | 1.25 | 1.08 |
May 22, 2023 | 1.10 | 0.00 | 0.00% | 1.10 | 1.11 | 1.07 |
May 19, 2023 | 1.08 | -0.01 | -0.92% | 1.09 | 1.11 | 1.07 |
May 18, 2023 | 1.08 | 0.08 | 8.00% | 1.00 | 1.09 | 1.00 |
May 17, 2023 | 1.00 | -0.01 | -0.99% | 1.01 | 1.02 | 0.98 |
May 16, 2023 | 0.99 | 0.02 | 2.06% | 0.97 | 1.00 | 0.93 |
May 15, 2023 | 1.00 | -0.07 | -6.54% | 1.07 | 1.09 | 0.99 |
May 12, 2023 | 1.04 | 0.00 | 0.00% | 1.04 | 1.07 | 0.98 |
May 11, 2023 | 1.05 | 0.05 | 5.00% | 1.00 | 1.07 | 0.92 |
May 10, 2023 | 1.13 | 0.14 | 14.14% | 0.99 | 1.19 | 0.98 |
May 9, 2023 | 0.96 | 0.02 | 2.13% | 0.94 | 0.98 | 0.92 |
May 8, 2023 | 0.89 | -0.08 | -8.25% | 0.97 | 0.99 | 0.85 |
May 5, 2023 | 0.98 | -0.01 | -1.01% | 0.99 | 1.00 | 0.94 |
Virios Therapeutics, Inc. Events
Kellaaeg (UTC) (UTC) | Riik | Sündmus |
---|---|---|
No events scheduled |
- Aastas
- Kvartalis
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Kogutulu | 0 | 0 | 0 | 0 | 0 |
Tulu | 0 | 0 | 0 | 0 | 0 |
Kogu tegevuskulu | 12.3153 | 15.6409 | 10.0054 | 2.1785 | 1.9615 |
Müük/Üldine/admin kulud, kokku | 4.24568 | 4.84525 | 9.81138 | 1.34232 | 1.10739 |
Uuringud ja arendus | 8.06963 | 10.7957 | 0.19401 | 0.83618 | 0.85411 |
Tulud majandustegevusest | -12.3153 | -15.6409 | -10.0054 | -2.1785 | -1.9615 |
Intressitulud (kulu), muud tulud, neto | 0.06748 | -0.31933 | -0.38422 | -0.29513 | -0.1521 |
Muud, neto | 0.04322 | 0 | 0.00001 | ||
Netotulu enne makse | -12.2478 | -15.9603 | -10.3464 | -2.47363 | -2.11359 |
Netotulu pärast makse | -12.2478 | -15.9603 | -10.3464 | -2.47363 | -2.11359 |
Netotulu enne erikulusid | -12.2478 | -15.9603 | -10.3464 | -2.47363 | -2.11359 |
Netotulu | -12.2478 | -15.9603 | -10.3464 | -2.47363 | -2.11359 |
Arvestatav tulu, v a erikulud | -12.2478 | -15.9603 | -10.3464 | -2.47363 | -2.11359 |
Arvestatav tulu, koos erikuludega | -12.2478 | -15.9603 | -10.3464 | -2.47363 | -2.11359 |
Jaotamisele kuuluv netotulu | -12.2478 | -15.9603 | -10.3464 | -2.47363 | -2.11359 |
Keskmine jaotamisele kuuluv aktsia kohta | 11.0701 | 8.32931 | 8.30508 | 7.83249 | 7.83249 |
Jaotatav EPS, v a erakorralised kulud | -1.10639 | -1.91616 | -1.24579 | -0.31582 | -0.26985 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | |||
Jaotamisele kuuluv normaal-EPS | -1.10639 | -1.91616 | -1.24579 | -0.31582 | -0.26985 |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
---|---|---|---|---|---|
Kogutulu | 0 | 0 | 0 | 0 | 0 |
Tulu | 0 | 0 | 0 | 0 | 0 |
Kogu tegevuskulu | 2.08972 | 2.59232 | 3.67206 | 3.96121 | 4.18756 |
Müük/Üldine/admin kulud, kokku | 0.818 | 0.96995 | 1.26562 | 1.19211 | 1.26915 |
Uuringud ja arendus | 1.27171 | 1.62237 | 2.40644 | 2.7691 | 2.91841 |
Tulud majandustegevusest | -2.08972 | -2.59232 | -3.67206 | -3.96121 | -4.18756 |
Intressitulud (kulu), muud tulud, neto | 0.04516 | 0.01661 | 0.0048 | 0.00091 | -0.32374 |
Netotulu enne makse | -2.04456 | -2.57572 | -3.66726 | -3.96031 | -4.51129 |
Netotulu pärast makse | -2.04456 | -2.57572 | -3.66726 | -3.96031 | -4.51129 |
Netotulu enne erikulusid | -2.04456 | -2.57572 | -3.66726 | -3.96031 | -4.51129 |
Netotulu | -2.04456 | -2.57572 | -3.66726 | -3.96031 | -4.51129 |
Arvestatav tulu, v a erikulud | -2.04456 | -2.57572 | -3.66726 | -3.96031 | -4.51129 |
Arvestatav tulu, koos erikuludega | -2.04456 | -2.57572 | -3.66726 | -3.96031 | -4.51129 |
Jaotamisele kuuluv netotulu | -2.04456 | -2.57572 | -3.66726 | -3.96031 | -4.51129 |
Keskmine jaotamisele kuuluv aktsia kohta | 11.0701 | 18.3304 | 8.33039 | 8.33039 | 8.3304 |
Jaotatav EPS, v a erakorralised kulud | -0.18469 | -0.14052 | -0.44023 | -0.4754 | -0.54155 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | ||
Jaotamisele kuuluv normaal-EPS | -0.18469 | -0.14052 | -0.44023 | -0.4754 | -0.54155 |
- Aastas
- Kvartalis
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Käibevarad kokku | 8.36976 | 15.7767 | 31.4727 | 0.3159 | 0.0424 |
Raha ja lühiajalised investeeringud | 7.03099 | 14.0082 | 29.7954 | 0.30938 | 0.03003 |
Cash | 7.03099 | 14.0082 | 29.7954 | 0.30938 | 0.03003 |
Prepaid Expenses | 1.33876 | 1.7685 | 1.67737 | 0.00652 | 0.01237 |
Total Assets | 8.36976 | 15.7767 | 31.4727 | 0.3159 | 0.06594 |
Other Long Term Assets, Total | 0 | 0.02354 | |||
Total Current Liabilities | 1.04326 | 1.27562 | 1.53184 | 1.62087 | 1.32633 |
Accounts Payable | 0.57316 | 0.35386 | 0.36891 | 0.03542 | 0.14566 |
Accrued Expenses | 0.4701 | 0.92176 | 1.16294 | 1.58545 | 1.18068 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 1.04326 | 1.27562 | 1.53184 | 5.25841 | 1.32633 |
Total Long Term Debt | 0 | 0 | 0 | 3.63754 | 0 |
Long Term Debt | 0 | 3.63754 | 0 | ||
Total Equity | 7.32649 | 14.5011 | 29.9409 | -4.94251 | -1.2604 |
Preferred Stock - Non Redeemable, Net | 0 | 0.075 | 1.28348 | ||
Common Stock | 0.00183 | 0.00083 | 0.00083 | 12.6012 | 12.6012 |
Retained Earnings (Accumulated Deficit) | -56.1732 | -43.9254 | -27.9651 | -17.6187 | -15.1451 |
Total Liabilities & Shareholders’ Equity | 8.36976 | 15.7767 | 31.4727 | 0.3159 | 0.06594 |
Total Common Shares Outstanding | 18.3304 | 8.33039 | 8.30508 | 7.83249 | 7.83249 |
Additional Paid-In Capital | 63.4979 | 58.4256 | 57.9052 |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
---|---|---|---|---|---|
Käibevarad kokku | 8.36976 | 10.858 | 9.0401 | 12.5499 | 15.7767 |
Raha ja lühiajalised investeeringud | 7.03099 | 9.7884 | 7.69504 | 11.3522 | 14.0082 |
Cash | 7.03099 | 9.7884 | 7.69504 | 11.3522 | 14.0082 |
Prepaid Expenses | 1.33876 | 1.06958 | 1.34506 | 1.19769 | 1.7685 |
Total Assets | 8.36976 | 10.858 | 9.0401 | 12.5499 | 15.7767 |
Total Current Liabilities | 1.04326 | 1.63314 | 1.89773 | 1.8772 | 1.27562 |
Accounts Payable | 0.57316 | 0.67942 | 0.66554 | 0.33069 | 0.35386 |
Accrued Expenses | 0.4701 | 0.95373 | 1.23219 | 1.54651 | 0.92176 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 1.04326 | 1.63314 | 1.89773 | 1.8772 | 1.27562 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Total Equity | 7.32649 | 9.22484 | 7.14236 | 10.6727 | 14.5011 |
Preferred Stock - Non Redeemable, Net | |||||
Common Stock | 0.00183 | 0.00183 | 0.00083 | 0.00083 | 0.00083 |
Additional Paid-In Capital | 63.4979 | 63.3517 | 58.6945 | 58.5575 | 58.4256 |
Retained Earnings (Accumulated Deficit) | -56.1732 | -54.1287 | -51.5529 | -47.8857 | -43.9254 |
Total Liabilities & Shareholders’ Equity | 8.36976 | 10.858 | 9.0401 | 12.5499 | 15.7767 |
Total Common Shares Outstanding | 18.3304 | 18.3304 | 8.33039 | 8.33039 | 8.33039 |
- Aastas
- Kvartalis
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Netotulu/algväärtus | -12.2478 | -15.9603 | -10.3464 | -2.47363 | -2.11359 |
Raha majandustegevusest | -11.4678 | -15.6896 | -3.8952 | -2.09215 | -1.19596 |
Mittelikviidsed varad | 0.58266 | 0.32288 | 7.42526 | 0.065 | 0.04851 |
Muutused tööjõus | 0.19738 | -0.05219 | -0.97406 | 0.31648 | 0.86913 |
Rahavood investeeringutelt | 4.49061 | -0.0976 | 33.3812 | 2.37151 | 1.15047 |
Rahavoogudesse investeerimine | 4.49061 | -0.29517 | -0.13826 | -0.05849 | 1.15047 |
Laenu väljastamine (kustutamine), neto | 0 | 1.99413 | 2.43 | 0 | |
Rahaline kogumuutus | -6.97719 | -15.7872 | 29.486 | 0.27936 | -0.04549 |
Makstud intressid | 0 | 0.01255 | |||
Aktsiate emiteerimine (tagasiost), neto | 0 | 0.19756 | 31.5253 |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -12.2478 | -10.2033 | -7.62756 | -3.96031 | -15.9603 |
Cash From Operating Activities | -11.4678 | -8.79639 | -6.31314 | -2.65602 | -15.6896 |
Non-Cash Items | 0.58266 | 0.43313 | 0.26886 | 0.13191 | 0.32288 |
Changes in Working Capital | 0.19738 | 0.97376 | 1.04556 | 1.17239 | -0.05219 |
Cash From Financing Activities | 4.49061 | 4.5766 | 0 | 0 | -0.0976 |
Financing Cash Flow Items | 4.49061 | 4.5766 | 0 | 0 | -0.29517 |
Issuance (Retirement) of Stock, Net | 0 | 0 | 0 | 0 | 0.19756 |
Issuance (Retirement) of Debt, Net | 0 | ||||
Net Change in Cash | -6.97719 | -4.21979 | -6.31314 | -2.65602 | -15.7872 |
Cash Interest Paid | 0 |
Investori nimi | Investori liik | Ringluse protsent | Hoitud osakud | Muutus osakutes | Hoidmise kuupäev | Hinnang käibele |
---|---|---|---|---|---|---|
Corday (Brian David) | Individual Investor | 7.0919 | 1299980 | 36782 | 2023-05-15 | LOW |
Pridgen (William L) | Individual Investor | 4.0694 | 745944 | 0 | 2023-04-25 | |
Ionic Ventures LLC | Venture Capital | 3.804 | 697292 | -1132708 | 2022-12-31 | LOW |
Susquehanna International Group, LLP | Investment Advisor | 0.8827 | 161811 | 161811 | 2023-03-31 | MED |
Burch (Richard Alan) | Individual Investor | 0.8057 | 147681 | 0 | 2023-04-25 | |
Envestnet Asset Management, Inc. | Investment Advisor | 0.5957 | 109196 | 93050 | 2022-12-31 | LOW |
PVG Asset Management Corporation | Investment Advisor | 0.4397 | 80590 | 0 | 2022-12-31 | HIGH |
Warberg Asset Management LLC | Hedge Fund | 0.4078 | 74750 | -85250 | 2023-03-31 | HIGH |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.3289 | 60286 | 0 | 2023-03-31 | LOW |
Renaissance Technologies LLC | Hedge Fund | 0.264 | 48400 | -187000 | 2023-03-31 | HIGH |
Advisor Group, Inc | Investment Advisor | 0.2205 | 40421 | 12592 | 2023-03-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.2142 | 39255 | 1344 | 2023-03-31 | LOW |
Duncan (Gregory Scott) | Individual Investor | 0.1771 | 32461 | 0 | 2023-04-25 | LOW |
Raymond James & Associates, Inc. | Research Firm | 0.1637 | 30000 | 0 | 2023-03-31 | LOW |
Cetera Investment Advisers LLC | Investment Advisor | 0.146 | 26769 | 10621 | 2023-03-31 | MED |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 0.1135 | 20798 | -127853 | 2023-03-31 | LOW |
Cetera Advisors LLC | Investment Advisor | 0.112 | 20524 | 0 | 2023-03-31 | LOW |
Regions Investment Management, Inc. | Investment Advisor | 0.1095 | 20072 | 0 | 2023-03-31 | LOW |
Jane Street Capital, L.L.C. | Research Firm | 0.0985 | 18058 | 18058 | 2023-03-31 | HIGH |
Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.0864 | 15836 | 0 | 2023-03-31 | LOW |
Miks valida Capital.com? Meie numbrid räägivad iseenda eest.
Capital.com Group535K+
Kauplejad
87K+
Igakuiste aktiivsete klientide arv
$113M+
Igakuine investeerimise maht
$64M+
Igakuiselt välja võetud
Kauplemiskalkulaator
Arvutage oma hüpoteetiline võit/kaotus, kui oleksite avanud CFD-tehingu ühel kindlal kuupäeval (valige kuupäev) ja sulgenud teisel kuupäeval (valige kuupäev).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Virios Therapeutics, Inc. Company profile
Ettevõttest Virios Therapeutics, Inc.
Virios Therapeutics, Inc., varem Virios Therapeutics, LLC., on arendusjärgus biotehnoloogia ettevõte, mis keskendub viirusevastaste ravimeetodite arendamisele, et ravida haigusi, mis on seotud viiruse põhjustatud ebanormaalse immuunvastusega, nagu fibromüalgia (FM). Tema peamine arenduskandidaat on IMC-1, mis on famtsikloviiri ja tselekoksiibi fikseeritud annuse kombinatsioon. IMC-1 kujutab endast kombineeritud viirusevastast ravi, mille eesmärk on sünergiliselt pärssida Herpes Simplex Virus-1 (HSV-1) aktiveerimist ja replikatsiooni. Selle HSV-1 on krooniliste haiguste, nagu FM, ärritunud soolehaiguse (IBS), kroonilise väsimuse sündroomi ja funktsionaalse somaatilise sündroomi algpõhjus. Ettevõte arendab oma esialgset ravimikandidaati IMC-1 fibromüalgia all kannatavate inimeste jaoks.
Industry: | Bio Therapeutic Drugs |
44 Milton Avenue
ALPHARETTA
GEORGIA 30009
US
Tuluaruanne
- Annual
- Quarterly
Teised on vaadanud veel
Kas otsite jätkuvalt vahendajat, keda saab usaldada?
Ühinege 535,000+ kauplejaga üle kogu maailma, kes valisid kauplemiseks veebisaidi Capital.com